Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Cash Flow 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Cash Flow | -123.3M | -167.6M | 11.9M | -179.9M | -74.8M |
| Depreciation & Amort. | — | — | — | — | — |
| Investing Activities | |||||
| Capital Expenditure | 138,000 | 157,000 | 1.2M | 2.5M | 353,000 |
| Free Cash Flow | -123.5M | -167.8M | 10.7M | -182.4M | -75.2M |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
Amylyx Pharmaceuticals, Inc. Common Stock Cash Flow — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) cash flow over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's cash flow history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's cash flow by year and by quarter, including the growth rate.